Drug Type Small molecule drug |
Synonyms M6G, Morphine 6-beta-D-glucopyranosiduronide, Morphine 6-glucuronide + [5] |
Target |
Action agonists |
Mechanism μ opioid receptor agonists(Mu opioid receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationSpecial Review Project (China) |
Molecular FormulaC23H27NO9 |
InChIKeyGNJCUHZOSOYIEC-GAROZEBRSA-N |
CAS Registry20290-10-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Morphine-6-glucuronide | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain, Postoperative | Phase 3 | Czechia | 01 Nov 2005 | |
Pain, Postoperative | Phase 3 | France | 01 Nov 2005 | |
Pain, Postoperative | Phase 3 | Germany | 01 Nov 2005 | |
Pain, Postoperative | Phase 3 | Netherlands | 01 Nov 2005 | |
Pain, Postoperative | Phase 3 | Poland | 01 Nov 2005 | |
Pain, Postoperative | Phase 3 | United Kingdom | 01 Nov 2005 | |
Moderate pain | Phase 1 | China | 01 Jul 2019 | |
Severe pain | Phase 1 | China | 01 Jul 2019 |
Not Applicable | 100 | Morphine (Morphine US) | odtwkpxfjg(utxacncwdz) = pdybqnbmlt udbcsbntum (lqkgpupxaz, 1096.761) View more | - | 22 Feb 2019 | ||
Morphine (Morphine FA) | odtwkpxfjg(utxacncwdz) = zpjmwpudsp udbcsbntum (lqkgpupxaz, 1590.784) View more | ||||||
Phase 3 | - | qgyrzhvaef(acrssnezze) = vxswttbgxw qxclqdpcwm (yggknflsmv, 2.6) View more | Positive | 07 Oct 2017 | |||
Placebo | qgyrzhvaef(acrssnezze) = njbtmljqsx qxclqdpcwm (yggknflsmv, 2.1) View more |